Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
February 2nd, 2024 |
Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
January 27th, 2025 |
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed) |
National Institutes of Health |
October 12th, 2023 |
Sustained HIV epidemic control and improved health outcomes through strengthened primary health care and social service platforms in Botswana |
South Africa USAID Pretoria |
November 22nd, 2023 |
Developing Salivary Components as Therapeutics for Oral Health (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
November 22nd, 2023 |
Developing Salivary Components as Therapeutics for Oral Health (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 11th, 2023 |
Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed) |
National Institutes of Health |
November 22nd, 2023 |
Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) |
National Institutes of Health |
October 30th, 2023 |
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) |
National Institutes of Health |
November 30th, 2023 |
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) |
National Institutes of Health |
June 10th, 2024 |
Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed) |
National Institutes of Health |
November 15th, 2023 |
Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial Required) |
National Institutes of Health |
February 14th, 2024 |
Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
September 27th, 2023 |
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) |
National Institutes of Health |
September 27th, 2023 |
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional) |
National Institutes of Health |
September 27th, 2023 |
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional) |
National Institutes of Health |
October 31st, 2023 |
Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional) |
National Institutes of Health |
October 30th, 2026 |
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) |
National Institutes of Health |
January 7th, 2027 |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
November 19th, 2026 |
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
February 7th, 2024 |
Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
|
January 7th, 2027 |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) |
National Institutes of Health |
July 6th, 2028 |
AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) |
Agency for Health Care Research and Quality |
May 26th, 2028 |
AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) |
Agency for Health Care Research and Quality |
September 7th, 2025 |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
National Institutes of Health |
November 19th, 2024 |
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) |
National Institutes of Health |
October 30th, 2023 |
HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Coordination and Translation Center (U2C Clinical Trial Optional) |
National Institutes of Health |
October 30th, 2023 |
HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Methodology and Advanced Analytics Resource Center (UM1 Clinical Trial Not Allowed) |
National Institutes of Health |
August 5th, 2024 |
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional) |
National Institutes of Health |
September 5th, 2023 |
Emergency Department Substance Use Surveillance System |
Office of National Drug Control Policy |
November 20th, 2023 |
HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain: Acute Pain Clinical Trials Program (U01 Clinical Trial Required) |
National Institutes of Health |
November 20th, 2023 |
HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain Program Resource and Data Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
August 13th, 2026 |
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2026 |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
April 5th, 2024 |
Fiscal Year (FY) 2024 AmeriCorps State and National Native Nation Planning Grants |
AmeriCorps |
April 5th, 2024 |
Fiscal Year (FY) 2024 AmeriCorps State and National Native Nation Grants |
AmeriCorps |
November 29th, 2023 |
National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2024 |
Pediatric Environmental Health Specialty Units (PEHSU) |
Centers for Disease Control ATSDR |
May 7th, 2027 |
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial |
National Institutes of Health |
October 23rd, 2023 |
NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
February 1st, 2024 |
VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |